NEWARK,
Del., Aug. 5, 2024 /PRNewswire/ -- The National
Institute for Innovation in Manufacturing Biopharmaceuticals is
pleased to announce two Requests for Information (RFI) related to
universal connectivity and federated learning as part of the
Institute's Big Data Program. The Institute invites submissions
from data science experts with knowledge of connectivity systems
and federated learning.
Universal Connectivity for In-process Analytics in
Biopharmaceutical Manufacturing (RFI 2024.1) seeks information on
potential solutions for a universal connectivity system for at-line
and/or inline analytical instrumentation. This system is envisioned
as an OT/IT core to facilitate seamless data integration and
advanced analytics within biomanufacturing processes, thus enabling
data-driven decision making and process optimization. The
submission deadline is August 30,
2024. Learn more about the Universal Connectivity
RFI.
Hybrid Model Federated Learning (RFI 2024.2) requests
information on innovative approaches that combine federated
learning with hybrid models (combining Physics-Based and AI/ML
data-driven methodologies) specifically tailored for
biopharmaceutical manufacturing processes. This request aims to
gather insights and concepts for achieving integration and
operationalization of these models in a practical,
industry-relevant context. The submission deadline is
September 23, 2024. Learn more
about the Hybrid Model Federated Learning RFI.
"Enhanced data integration and predictive modeling are essential
to help biopharmaceutical manufacturers make data-driven,
analytics-based decisions to optimize manufacturing processes.
These two RFIs will help NIIMBL's Big Data Program tackle these
challenges for the industry," said Roger
Hart, NIIMBL Senior Fellow and Big Data Program Lead.
NIIMBL's Big Data Program aims to accelerate the development and
adoption of data-driven innovation and standards to increase the
speed and resilience of biopharmaceutical manufacturing. The
Program includes five workstreams focused on data creation,
transformation, storage, prediction, and control.
These RFIs aim to collect information only and are not a
solicitation for funding.
Click here to learn more about the Universal Connectivity
RFI.
Click here to learn more about the Hybrid Model Federated
Learning RFI.
To learn more about NIIMBL, including how to be a member, visit
NIIMBL.org.
About NIIMBL
The National Institute for Innovation in Manufacturing
Biopharmaceuticals (NIIMBL) is a public-private partnership whose
mission is to accelerate biopharmaceutical innovation, support the
development of standards that enable more efficient and rapid
manufacturing capabilities, and educate and train a world-leading
biopharmaceutical manufacturing workforce, fundamentally advancing
U.S. competitiveness in this industry. NIIMBL is part of
Manufacturing USA®, a diverse network of federally sponsored
manufacturing innovation institutes, and is funded through a
cooperative agreement with the National Institute of Standards and
Technology (NIST) in the U.S. Department of Commerce with
significant additional support from its members.
Contact
News Media
Daniel Maiese
Communications Manager
302-831-3824
dmaiese@udel.edu
View original content to download
multimedia:https://www.prnewswire.com/news-releases/niimbl-announces-2-rfis-focused-on-data-connectivity-and-federated-learning-for-biopharmaceutical-manufacturing-302213674.html
SOURCE National Institute for Innovation in Manufacturing
Biopharmaceuticals (NIIMBL)